Literature DB >> 28905195

Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine.

Zhi-Qing Duan1,2, Yan Li3, Lu Li3.   

Abstract

Molecular constituents regulated by the microenvironment components profoundly influence the propensity of cancer metastasis, a key event of estimating therapeutic actions of anticancer drugs. On one hand, kynurenine (Kyn), one of the microenvironment components, plays key roles in the metastasis of cancer cells in vivo; on the other hand, forkhead box O3 (FOXO3) can serve as a therapeutic target of various anticancer drugs. However, the effect of Kyn on FOXO3 is still not clear. The current study demonstrated that the selected dose of Kyn significantly upregulated the FOXO3 protein rather than FOXO3 messenger RNA (mRNA) in the lung cancer 95D cells. However, only 50 μM Kyn markedly reduced miR-30b expression at the same time. Furthermore, the direct interaction between FOXO3 mRNA and miR-30b was also confirmed by dual-luciferase assay system. More importantly, miR-30b-induced suppression of FOXO3 protein was significantly attenuated on Kyn treatment, which demonstrated that Kyn-mediated increase of FOXO3 depended at least partly on miR-30b. In addition, Kyn-mediated upregulation of migration, a method of measuring cancer metastasis, was markedly decreased on miR-30b treatment, in vitro, which was altered in some degree via regulating FOXO3. These results suggest that miR-30b plays important roles in Kyn-induced increase of FOXO3 expression.

Entities:  

Keywords:  FOXO3; Kynurenine; Metastasis; miR-30b

Mesh:

Substances:

Year:  2017        PMID: 28905195     DOI: 10.1007/s12026-017-8949-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  26 in total

Review 1.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells.

Authors:  Chih-Chao Chang; Qing-Yin Zhang; Zhuoru Liu; Raphael A Clynes; Nicole Suciu-Foca; George Vlad
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

4.  Novel energy-saving strategies to multiple stressors in birds: the ultradian regulation of body temperature.

Authors:  Glenn J Tattersall; Damien Roussel; Yann Voituron; Loïc Teulier
Journal:  Proc Biol Sci       Date:  2016-09-28       Impact factor: 5.349

5.  Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival.

Authors:  Debbie M Ferns; Ido P Kema; Marrije R Buist; Hans W Nijman; Gemma G Kenter; Ekaterina S Jordanova
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

6.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

7.  Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L.

Authors:  Pedro J Real; Adalberto Benito; Jorge Cuevas; Maria T Berciano; Ana de Juan; Paul Coffer; Javier Gomez-Roman; Miguel Lafarga; Jose M Lopez-Vega; Jose L Fernandez-Luna
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

8.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

9.  MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.

Authors:  Xiaolin Sun; Shuhua Zhao; Huanan Li; Hanwen Chang; Zhen Huang; Zhi Ding; Lei Dong; Jiangning Chen; Yuhui Zang; Junfeng Zhang
Journal:  J Cell Physiol       Date:  2016-06-30       Impact factor: 6.384

10.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

View more
  5 in total

1.  Promoting epithelial-to-mesenchymal transition by D-kynurenine via activating aryl hydrocarbon receptor.

Authors:  Zhiqing Duan; Yan Li; Lu Li
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

2.  Involvement of Aryl Hydrocarbon Receptor in L-Kynurenine-Mediated Parathyroid Hormone-Related Peptide Expression.

Authors:  Zhiqing Duan; Jiangong Lu
Journal:  Horm Cancer       Date:  2019-01-28       Impact factor: 3.869

3.  Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis.

Authors:  Wenbiao Chen; Jingjing Jiang; Lan Gong; Zheyue Shu; Dairong Xiang; Xujun Zhang; Kefan Bi; Hongyan Diao
Journal:  J Exp Clin Cancer Res       Date:  2021-01-04

4.  Accumulation of kynurenine elevates oxidative stress and alters microRNA profile in human bone marrow stromal cells.

Authors:  Sherwood Dalton; Kathryn Smith; Kanwar Singh; Helen Kaiser; Ravindra Kolhe; Ashis K Mondal; Andrew Khayrullin; Carlos M Isales; Mark W Hamrick; William D Hill; Sadanand Fulzele
Journal:  Exp Gerontol       Date:  2019-11-30       Impact factor: 4.032

5.  Down-Regulation of microRNA-30d Alleviates Intervertebral Disc Degeneration Through the Promotion of FOXO3 and Suppression of CXCL10.

Authors:  Peng Xia; Xu Gao; Fang Li; Liwei Shao; Yifu Sun
Journal:  Calcif Tissue Int       Date:  2020-10-28       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.